J-Pharma (TKS: 520A)

Tokyo, Japan · Founded 2005 · Publicly Held

J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. J-Pharma (TKS: 520A) is based in Tokyo, Japan and was founded in 2005. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $99.4 million (Mar 2026). It has raised $83.1 million.

Last price · $/share
—
Implied valuation
$99.4M
Total raised
$83.1M
Last round
—

Who backs J-Pharma (TKS: 520A)?

30 investors
InvestorType
Mitsubishi UFJ CapitalOther
F-Prime CapitalVenture capital
Eight RoadsAsset manager
Japan External Trade OrganizationOther
JIC Venture Growth InvestmentsVenture capital
Nippon Venture CapitalVenture capital
FFG Venture Business PartnersOther
UntroDOther
Mitsui Sumitomo Insurance Co.Other
QR InvestmentOther
+ 20 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

J-Pharma (TKS: 520A) investors

30 investors are on record for J-Pharma (TKS: 520A), including Mitsubishi UFJ Capital, F-Prime Capital, Eight Roads and Japan External Trade Organization. By type, the record holds 4 venture capital firms and 1 asset manager.

Free account
More of J-Pharma (TKS: 520A) with a free account
  • ·The complete investor list: 30 names
  • ·Watch J-Pharma (TKS: 520A): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 30 firms already write checks for companies like J-Pharma (TKS: 520A). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View